Similar articles for PMID: 25987628

Year	Number of Results
1901	1
2003	1
2005	2
2007	1
2009	3
2010	6
2011	4
2012	6
2013	4
2014	13
2015	13
2016	13
2017	9
2018	6
2019	7
2020	4
2021	2
2022	1
2024	0

1

Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection.

Cates JE, Mitrani-Gold FS, Li G, Mundy LM. Cates JE, et al. Antimicrob Agents Chemother. 2015 Aug;59(8):4510-20. doi: 10.1128/AAC.00679-15. Epub 2015 May 18. Antimicrob Agents Chemother. 2015. PMID: 25987628 Free PMC article.

2

Comparative efficacy of antibiotics for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a systematic review and network meta-analysis.

Thom H, Thompson JC, Scott DA, Halfpenny N, Sulham K, Corey GR. Thom H, et al. Curr Med Res Opin. 2015 Aug;31(8):1539-51. doi: 10.1185/03007995.2015.1058248. Epub 2015 Jun 30. Curr Med Res Opin. 2015. PMID: 26038985 Review.

3

Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non-Lower-Extremity Infections_{Pooled Analysis of Two Phase 3 Trials}.

Joseph WS, Culshaw D, Anuskiewicz S, De Anda C, Prokocimer P. Joseph WS, et al. J Am Podiatr Med Assoc. 2017 Jul;107(4):264-271. doi: 10.7547/15-218. Epub 2016 Aug 17. J Am Podiatr Med Assoc. 2017. PMID: 27533787

4

CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.

Friedland HD, O'Neal T, Biek D, Eckburg PB, Rank DR, Llorens L, Smith A, Witherell GW, Laudano JB, Thye D. Friedland HD, et al. Antimicrob Agents Chemother. 2012 May;56(5):2231-6. doi: 10.1128/AAC.05738-11. Epub 2012 Feb 6. Antimicrob Agents Chemother. 2012. PMID: 22314524 Free PMC article. Clinical Trial.

5

Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Trials.

Sandison T, De Anda C, Fang E, Das AF, Prokocimer P. Sandison T, et al. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02687-16. doi: 10.1128/AAC.02687-16. Print 2017 May. Antimicrob Agents Chemother. 2017. PMID: 28264845 Free PMC article. Clinical Trial.

6

Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective.

Huang X, Beresford E, Lodise T, Friedland HD. Huang X, et al. Am J Health Syst Pharm. 2013 Jun 15;70(12):1057-64. doi: 10.2146/ajhp120438. Am J Health Syst Pharm. 2013. PMID: 23719884

7

Omadacycline for Acute Bacterial Skin and Skin Structure Infections.

Abrahamian FM, Sakoulas G, Tzanis E, Manley A, Steenbergen J, Das AF, Eckburg PB, McGovern PC. Abrahamian FM, et al. Clin Infect Dis. 2019 Aug 1;69(Suppl 1):S23-S32. doi: 10.1093/cid/ciz396. Clin Infect Dis. 2019. PMID: 31367742 Free PMC article. Clinical Trial.

8

Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection.

Lv X, Alder J, Li L, O'Riordan W, Rybak MJ, Ye H, Zhang R, Zhang Z, Zhu X, Wilcox MH. Lv X, et al. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e02252-18. doi: 10.1128/AAC.02252-18. Print 2019 Jul. Antimicrob Agents Chemother. 2019. PMID: 30988146 Free PMC article. Clinical Trial.

9

Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials.

Corey GR, Wilcox MH, Gonzalez J, Jandourek A, Wilson DJ, Friedland HD, Das S, Iaconis J, Dryden M. Corey GR, et al. Int J Antimicrob Agents. 2019 Jun;53(6):830-837. doi: 10.1016/j.ijantimicag.2019.01.016. Epub 2019 Feb 1. Int J Antimicrob Agents. 2019. PMID: 30716446 Free article.

10

Outpatient treatment of acute bacterial skin and skin structure infections (ABSSSI) with tedizolid phosphate and linezolid in patients in the United States: Subgroup analysis of 2 randomized phase 3 trials.

De Anda C, Anuskiewicz S, Prokocimer P, Vazquez J. De Anda C, et al. Medicine (Baltimore). 2017 Dec;96(52):e9163. doi: 10.1097/MD.0000000000009163. Medicine (Baltimore). 2017. PMID: 29384903 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

86 results

Results by year